Delivery Order SPE2DB25D3005-SPE2DB25FQBKT
Award Date
1/3/25
Potential Completion Date
1/6/25
Potential Value
$55K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the cancer medication Kisqali. The $43,545.12 firm-fixed-price delivery order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. This single-award IDC allows Amerisourcebergen to deliver a comprehensive range of pharmaceutical...
This federal contract award is a delivery order placed by the Defense Logistics Agency (DLA) with AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Kisqali 600 mg daily dose tablets, a specialty medication used to treat cancer. The award has a total ceiling value of $13,591.56 and an ultimate completion date of November 4, 2024. This contract is not designated with any set-aside requirements, indicating open...
The U.S. Defense Logistics Agency (DLA) has awarded a $27,941.12 firm-fixed price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of Kisqali 400 mg daily dose medication. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, enabling the agency to efficiently procure a wide range of pharmaceutical products and medical...
This federal contract award, valued at $26,443.27, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, with an ultimate completion date of January 6, 2025.
The contract is not designated with a set-aside requirement, indicating open competition. It involves the delivery of Kisqali 600 mg daily dose pharmaceutical products,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $46,662.57 firm fixed-price delivery order is for KISQALI 600 MG DAILY DOSE 63S, a pharmaceutical product. The contract has an ultimate completion date of January 3, 2025.
AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Kisqali 400 mg daily dose 42s. The contract has a ceiling value of $47,706.96 and a completion date of November 13, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of $49,332.04 worth of the pharmaceutical product Kisqali 600 mg daily dose (63s). This delivery order was placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. The...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. The $83,218.82 firm fixed-price delivery order is for the supply of the medication Kisqali (ribociclib) 600 mg daily dose product, with a period of performance through May 15, 2024.
Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product Kisqali 400 mg Daily Dose 42s to the U.S. government. The contract has a ceiling value of $20,993.59 and a completion date of May 16, 2024. It was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a major agency within the Department of Defense (DoD) responsible for providing logistics and acquisition services to the U.S. Armed...
This federal contract award is a delivery order worth $11,338.34 awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The award is for the drug "KISQALI 200 MG DAILY DOSE UU 21S" and has an ultimate completion date of December 30, 2024. The contract is a firm fixed price arrangement with no set-aside designation.
AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...